Yingjian Chen
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction to "Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease".
Journal: Journal of agricultural and food chemistry
Published: December 05, 2023
Correction: Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 19, 2023
Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor).
Journal: Signal transduction and targeted therapy
Published: March 09, 2023
Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity.
Journal: Molecular medicine (Cambridge, Mass.)
Published: January 31, 2023
Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Journal: EMBO reports
Published: October 28, 2022
Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease.
Journal: Journal of agricultural and food chemistry
Published: October 27, 2022
Hepatic ZBTB22-mediated detoxification ameliorates acetaminophen-induced liver injury by inhibiting pregnane X receptor signaling.
Journal: iScience
Published: October 10, 2022
Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress.
Journal: Frontiers in pharmacology
Published: August 25, 2022
Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor.
Journal: Frontiers in pharmacology
Published: July 22, 2022
Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced Hepatotoxicity.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 26, 2021
Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients.
Journal: BioMed research international
Published: September 18, 2020
Research Status of Differentially Expressed Noncoding RNAs in Type 2 Diabetes Patients.
Journal: BioMed research international
Published: July 30, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026